← Back to search
PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD.
NEW TAIPEI CITY, 248
UnclaimedClaim this profile (free)
Prime contracting experience
15 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | THERAPEUTIC TESTING IN MURINE MODELS OF BACTERIAL INFECTION | 75N93024D00017USAspending | $545,542 | Sep 30, 2026 | Sep 30, 2026 – Sep 29, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | MOUSE MODEL OF NEISSERIA GONORRHOEAE INFECTION | 75N93024D00017USAspending | $621,336 | Jul 21, 2026 | Jul 22, 2026 – Jul 14, 2031 |
| Prime | Department of Health and Human Services National Institutes of Health | MOUSE MODEL OF NEISSERIA GONORRHOEAE INFECTION | HHSN272201700020IUSAspending | $331,260 | Mar 19, 2025 | Jul 12, 2024 – Jul 11, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | A94 - TESTING IN MURINE MODELS OF BACTERIAL INFECTION | HHSN272201700020IUSAspending | $503,403 | Mar 18, 2025 | Jul 10, 2024 – Jul 9, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | MURINE MODELS OF UTI INFECTION CAUSED BY ANTIBIOTIC-RESISTANT BACTERIA | HHSN272201700020IUSAspending | $599,260 | Oct 31, 2024 | Jul 19, 2023 – Feb 27, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | PRE-CLINICAL MODELS OF INFECTIOUS DISEASE | HHSN272201700020IUSAspending | $1,239,019 | Sep 5, 2024 | Aug 31, 2023 – Feb 7, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | A-10 ""MURINE MODELS OF LUNG INFECTION - ANTIBIOTIC-RESISTANT PSEUDOMONAS AERUGINOSA" | HHSN272201700020IUSAspending | $506,429 | Apr 15, 2024 | Jun 5, 2018 – Aug 15, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | PRECLINICAL MODELS OF INFECTIOUS DISEASES | HHSN272201700020IUSAspending | $680,842 | Feb 6, 2024 | Sep 7, 2021 – Jul 30, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | THERAPEUTIC TESTING IN MURINE MODELS OF BACTERIAL THIGH, LUNG AND PERITONITIS INFECTIONS A-32 | HHSN272201700020IUSAspending | $652,380 | Jan 29, 2024 | Jul 1, 2019 – Jun 30, 2020 |
| Prime | Department of Health and Human Services National Institutes of Health | PCMID IDIQ | HHSN272201700020IUSAspending | $1,197,620 | Jan 29, 2024 | Aug 12, 2022 – Aug 11, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | TO AWARD BASE CONTRACT FOR PCMID PROJECT. | HHSN272201700020IUSAspending | $336,528 | Jan 29, 2024 | Jan 22, 2021 – Jan 24, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | TASK A42 THERAPEUTIC TESTING IN MURINE MODELS OF BACTERIAL THIGH, LUNG AND PERITONITIS INFECTIONS | HHSN272201700020IUSAspending | $933,804 | Jan 29, 2024 | Jul 9, 2020 – Jul 31, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | PRE-CLINICAL MODELS OF INFECTIOUS DISEASES- THERAPEUTIC TESTING IN MURINE MODELS OF BACTERIAL INFECTION | HHSN272201700020IUSAspending | $952,930 | Jan 29, 2024 | Aug 10, 2021 – Aug 9, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | PCMID TASK AREA A67 | HHSN272201700020IUSAspending | $288,577 | Jan 29, 2024 | May 16, 2022 – May 17, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | PRE-CLINICAL MODELS OF INFECTIOUS DISEASES | HHSN272201700020IUSAspending | $332,878 | Dec 14, 2023 | Sep 2, 2020 – Sep 1, 2021 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.